Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors

Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors

Immune checkpoint blockade (ICB) has emerged as a novel therapeutic tool for cancer therapy in the last decade. Unfortunately, a small number of patients benefit from approved immune checkpoint inhibitors (ICIs). Therefore, multiple studies are being conducted to find new ICIs and combination strate...

Full description

Bibliographic Details
Main Authors: Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, Sheila Spada, Sumit Mukherjee
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biology
Subjects:
cancer treatment
immune response
cancer therapeutic strategy
tumor immune escape
immune-oncology
tumor immune microenvironment
Online Access:https://www.mdpi.com/2079-7737/12/2/218

Similar Items

Similar Items